Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis.

@article{Zhang2007ChemicalKO,
  title={Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis.},
  author={Yong-mei Zhang and Shigeru Chohnan and Kristopher G. Virga and Robert David Stevens and Olga R Ilkayeva and Brett R. Wenner and James R. Bain and Christopher B. Newgard and Richard E. Lee and Charles O. Rock and Suzanne Jackowski},
  journal={Chemistry \& biology},
  year={2007},
  volume={14 3},
  pages={
          291-302
        }
}

Figures from this paper

Pantothenate Kinase 1 Is Required to Support the Metabolic Transition from the Fed to the Fasted State

TLDR
The importance of PanK1 and elevated liver CoA levels during fasting to support the metabolic transition from glucose utilization and fatty acids synthesis to gluconeogenesis and fatty acid oxidation is illustrated andPanK1 may be a suitable target for therapeutic intervention in metabolic disorders that feature hyperglycemia and hypertriglyceridemia.

Germline Deletion of Pantothenate Kinases 1 and 2 Reveals the Key Roles for CoA in Postnatal Metabolism

TLDR
The results revealed an important link between CoA and NADH levels, which was reflected by deficiencies in hepatic oleate synthesis and gluconeogenesis, and indicated that PanK1 and PanK2 can compensate for each other to supply tissue CoA, but PanK 1 is more important to CoA levels in liver whereas PanK 2 contributes more to coenzyme A synthesis in the brain.

Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia

TLDR
Therapeutic relief of CoA sequestration improves mitochondrial dysfunction in a propionic acidemia mouse model, providing preclinical proof of concept for PanK activators as a therapy to attenuate the underlying mitochondrial defect in PA.

Regulation of coenzyme A levels by degradation: the 'Ins and Outs'.

The role of impaired De novo Coenzyne A biosynthesis in pantothenate kinase-associated neurodegeneration

TLDR
Data suggest that pantethine may serve as a starting point to develop a possible treatment for PKAN, effective in mammalian cells with impaired function of pantothenate kinase and a potential niche for Drosophila as a model organism forPKAN-related research.

4′‐Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN

TLDR
This work took a new approach to investigating an existing mouse mutant of Pank2 and found that isolating the disease‐vulnerable brain revealed regional perturbations in CoA metabolism, iron homeostasis, and dopamine metabolism and functional defects in complex I and pyruvate dehydrogenase.

Extracellular 4'-phosphopantetheine is a source for intracellular coenzyme A synthesis.

TLDR
This study demonstrates an alternative mechanism that allows cells and organisms to adjust intracellular CoA levels by using exogenous CoA, and answers long-standing questions in fundamental cell biology and has major implications for the understanding of CoA-related diseases and therapies.
...

References

SHOWING 1-10 OF 61 REFERENCES

Regulation of coenzyme A biosynthesis

TLDR
Results point to pantothenate kinase as the primary enzymatic step that regulates the CoA content of E. coli.

Regulation of the biosynthesis of CoA at the level of pantothenate kinase.

TLDR
Pantothenate kinase activity was studied in preparations from livers of rats fed normal or clofibrate-enriched diets and it was found that free CoASH, dephospho-CoA and long-chain acyl- coA were less efficient inhibitors than acetyl- CoA.

Regulation of pantothenate kinase by coenzyme A and its thioesters.

Coenzyme A: back in action.

Pantothenate Kinase Regulation of the Intracellular Concentration of Coenzyme A*

TLDR
The concept that the expression and/or activity of PanK is a determining factor in the physiological regulation of the intracellular CoA concentration is supported.

Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance

TLDR
It is shown that, in rats fed a high-fat diet, whole-animal, muscle and liver insulin resistance is ameliorated following hepatic overexpression of malonyl–coenzyme A (CoA) decarboxylase (MCD), an enzyme that affects lipid partitioning.

Carnitine acyltransferases and their influence on CoA pools in health and disease.

Kinetics and regulation of pantothenate kinase from Escherichia coli.

Cloning, sequencing, and expression of the pantothenate kinase (coaA) gene of Escherichia coli

TLDR
Strains containing multiple copies of the coaA gene possessed 76-fold-higher specific activity of pantothenate kinase; however, there was only a 2.7-fold increase in the steady-state level of CoA.

Feedback Regulation of Murine Pantothenate Kinase 3 by Coenzyme A and Coenzyme A Thioesters*

TLDR
The distinct regulatory properties exhibited by the family of the pantothenate kinases allowed the rate of CoA biosynthesis to be controlled by regulatory signals from CoA thioesters involved in different branches of intermediary metabolism.
...